Newsletter - All News

Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research

Category

Continent

From

To

EnteroBiotix Completes Patient Recruitment in Phas...

EnteroBiotix Completes Patient Recruitment in Phas...

Category : Clinical Trial Update 20 November 2024

EnteroBiotix completes patient recruitment in phase 2 TrIuMPH study of EBX-102-02 in irritable bowel...

Alnylam Reports Interim Phase 1 Data of Nucresiran...

Alnylam Reports Interim Phase 1 Data of Nucresiran...

Category : Approval/Launch 20 November 2024

Alnylam reports interim phase 1 data of nucresiran showing rapid knockdown of TTR that is sustained...

Foresee Pharma Gets Positive Recommendation from D...

Foresee Pharma Gets Positive Recommendation from D...

Category : Clinical Trial Update 19 November 2024

Foresee Pharma gets positive recommendation from DSMB to continue Casppian phase 3 study of leuproli...

European Union Recommends Approval of AstraZeneca’...

European Union Recommends Approval of AstraZeneca’...

Category : Approval/Launch 19 November 2024

European Union recommends approval of AstraZeneca’s Tagrisso for patients with unresectable EG...

AbbVie Receives European Marketing Approval for El...

AbbVie Receives European Marketing Approval for El...

Category : Approval/Launch 19 November 2024

AbbVie receives European marketing approval for Elahere for the treatment of platinum-resistant ovar...

‹
1
2

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.